Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:56 PM
Ignite Modification Date:
2025-12-24 @ 6:56 PM
NCT ID:
NCT00972257
Eligibility Criteria:
Inclusion Criteria:
* Consecutive, newly diagnosed or previously untreated POAG patients
* Patients with typical glaucomatous disc, or visual field damage
* Patient must have IOP (at 10:00 ± 1 hour)greater than 25 mm Hg
Exclusion Criteria:
* Uncontrolled glaucoma
* Distance best corrected Snellen visual acuity worse than 1/10
* Contraindications to brimonidine or dorzolamide and β-blockers
* History of lack of response (\<10% morning IOP reduction) to any medication
* Patient can not understand the instructions and adhere to medications
* Patient is a female of childbearing potential or lactating mother
* Prior surgery, past use of steroids (within 2 months)
* Severe dry eyes and use of contact lenses
* History of non-adherence
* Patients with closed angles
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
29 Years
Maximum Age:
80 Years
Study:
NCT00972257
Study Brief:
Protocol Section:
NCT00972257